CLINICAL_TRIALS
trial_result
· 2026-06-04
Clinical Trial Update: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents [Phase 3]
Summary
Phase 3 multicenter study assessing safety and immunogenicity of a live-attenuated chikungunya vaccine in adolescents has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Butantan Institute | Conditions: Chikungunya | Phase 3 | Status: COMPLETED | Results posted: 2026-06-04